newsfilter
← Latest News
GlobeNewswire·

Statera Biopharma Signs Letter of Intent for Merger with Worksite Labs

FORT COLLINS, Colo., March 15, 2023 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (OTCPK:STAB) (the "Company" or "Statera Biopharma"), a biopharmaceutical company creating next-generation immune therapies